Showing 1,401 - 1,420 results of 104,595 for search '(( 30 mean decrease ) OR ( 5 ((((step decrease) OR (we decrease))) OR (a decrease)) ))', query time: 1.53s Refine Results
  1. 1401
  2. 1402
  3. 1403

    AT2R blocker reduces T3-induced decreased levels of contractile proteins and attenuates T3-induced NO production. by Maria Alícia Carrillo-Sepúlveda (406779)

    Published 2013
    “…<p>Decreased levels of p-MLC (A) and α-actin (B) in VSMC treated with T3 (0.1 µM) for 24 h were attenuated in the VSMC pre-incubated with PD123319 (0.1 µM) for 30 min. …”
  4. 1404

    PLD2 and mTORC2 are required to convert increases in membrane tension to decreases in actin network assembly. by Alba Diz-Muñoz (236517)

    Published 2016
    “…<p><b>(A)</b> Prediction: Knockdown of the PLD2–mTORC2-based tension circuit should result in a slower decrease of actin nucleation following an increase in membrane tension. …”
  5. 1405
  6. 1406

    Image_1_TRAPS mutations in Tnfrsf1a decrease the responsiveness to TNFα via reduced cell surface expression of TNFR1.tif by Takahiko Akagi (13138338)

    Published 2022
    “…T79M is a known mutation responsible for TRAPS, whereas G87V is a TRAPS mutation that we have reported, and T90I is a variant of unknown significance. …”
  7. 1407

    Image_4_TRAPS mutations in Tnfrsf1a decrease the responsiveness to TNFα via reduced cell surface expression of TNFR1.tif by Takahiko Akagi (13138338)

    Published 2022
    “…T79M is a known mutation responsible for TRAPS, whereas G87V is a TRAPS mutation that we have reported, and T90I is a variant of unknown significance. …”
  8. 1408

    Image_7_TRAPS mutations in Tnfrsf1a decrease the responsiveness to TNFα via reduced cell surface expression of TNFR1.tif by Takahiko Akagi (13138338)

    Published 2022
    “…T79M is a known mutation responsible for TRAPS, whereas G87V is a TRAPS mutation that we have reported, and T90I is a variant of unknown significance. …”
  9. 1409

    Image_3_TRAPS mutations in Tnfrsf1a decrease the responsiveness to TNFα via reduced cell surface expression of TNFR1.tif by Takahiko Akagi (13138338)

    Published 2022
    “…T79M is a known mutation responsible for TRAPS, whereas G87V is a TRAPS mutation that we have reported, and T90I is a variant of unknown significance. …”
  10. 1410

    Image_6_TRAPS mutations in Tnfrsf1a decrease the responsiveness to TNFα via reduced cell surface expression of TNFR1.tif by Takahiko Akagi (13138338)

    Published 2022
    “…T79M is a known mutation responsible for TRAPS, whereas G87V is a TRAPS mutation that we have reported, and T90I is a variant of unknown significance. …”
  11. 1411

    Image_2_TRAPS mutations in Tnfrsf1a decrease the responsiveness to TNFα via reduced cell surface expression of TNFR1.tif by Takahiko Akagi (13138338)

    Published 2022
    “…T79M is a known mutation responsible for TRAPS, whereas G87V is a TRAPS mutation that we have reported, and T90I is a variant of unknown significance. …”
  12. 1412

    The decrease in lactate induced by pyruvate is blocked by inhibition of MAS and of the TCA cycle in HKI/HKII double KD cells. by Scott John (228011)

    Published 2023
    “…Following the decrease in lactate evoked by pyruvate, addition of AOA reversed this effect, causing a rapid increase in lactate. …”
  13. 1413

    The C allele at rs28416813-rev in <i>IL28B</i> promoter decreases luciferase expression. by Sreedhar Chinnaswamy (468287)

    Published 2013
    “…C) The C allele at rs28416813-rev consistently shows a reduction in luciferase activity by 20–30%. Results show the mean (76.5) of four independent experiments where samples were processed in triplicate and were controlled for transfection efficiency and were normalized to the G allele. …”
  14. 1414
  15. 1415

    DataSheet_1_Failure to decrease HbA1c levels following TB treatment is associated with elevated Th1/Th17 CD4+ responses.pdf by Robert Krause (504842)

    Published 2023
    “…Participants were stratified based on stable/increased HbA1c (n = 16) versus decreased HbA1c (n = 46) levels from treatment initiation to 12 month follow-up.…”
  16. 1416
  17. 1417
  18. 1418
  19. 1419
  20. 1420